Explore MOTS-C, the groundbreaking mitochondria-encoded longevity peptide. This intermediate research guide covers AMPK activation, centenarian studies, exercise synergy, and how MOTS-C fits into a comprehensive longevity stack.
Discover how cognitive peptides Semax and Selank may support focus, stress management, and mental recovery for athletes. A research-based beginner’s guide to nootropic peptides in sports performance.
A beginner’s guide to collagen peptides for skin health — covering how they work, clinical evidence for wrinkle and elasticity improvement, types of collagen, quality selection criteria, and how oral supplements compare to research peptides like GHK-Cu.
A 2026 research update on Epithalon — examining telomerase activation mechanisms, circadian restoration, lifespan extension animal data, and the latest international research findings on this pineal-derived longevity tetrapeptide.
A comprehensive research guide to TB-500 — covering its unique actin-regulation mechanism, muscle and tendon injury applications, comparison with BPC-157, dosing protocols, and safety profile for recovery-focused research.
A comprehensive research guide to GHK-Cu — the naturally occurring copper peptide with 50+ years of scientific evidence for collagen synthesis, wound healing, hair growth, and skin anti-aging applications.
A comprehensive research guide to the CJC-1295 and Ipamorelin GH secretagogue stack — covering mechanism, synergistic effects, performance applications, dosing protocols, and safety profile for athletic research contexts.
The definitive 2026 overview of the research peptide landscape — what has changed, the 7 peptide categories, key compounds, quality standards, regulatory reality, and how to get started. Essential reading for wellness professionals, digital nomads, and expats in Vietnam.
A goal-first decision framework for peptide selection — matching research objectives to the right compounds across recovery, weight management, longevity, performance, skin health, and cognitive categories. Includes a decision tree, stack guide, and common mistakes to avoid.
Retatrutide (LY3437943) is a first-in-class triple GIP/GLP-1/glucagon receptor co-agonist showing 24% weight reduction in Phase 2 trials. This expert guide covers the mechanism, TRIUMPH Phase 3 program, comparison with tirzepatide, and hepatic fat effects.
